News

COST Innovators Grant: 4 applications approved

Published on | 6 years ago

Programmes
COST COST

The Committee of Senior Officials (CSO) has approved the funding for 4 COST Innovators Grants (CIG). 

The COST Innovators Grant aims at enhancing the pace and success of breakthrough innovations, to build bridges between the scientific research performed in COST Actions and marketable applications and/or societal solutions and to explore innovation potential.

An overview of the approved COST Innovators Grants:

  • CIG-15102: Innovative and sustainable TecHnologies for reducing critical raw mAterials dependence for Cleaner transportation Applications 
  • CIG-15104: Industrial Machine Monitoring unplugged network 
  • CIG-15114: ePlatform for a “test bed” tool across EU for antimicrobial coating solutions in health care entering to the market 
  • CIG-15119: Nanofluids for convective heat transfer devices 

The full COST press release can be found here: https://www.cost.eu/news/cost-innovators-grant-4-applications-approved/

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1948 articles available search in articles 

Testimonial

ERC grants awarded to professor Inez Germeys

Professor Inez Germeys leads the Center for Contextual Psychiatry at KU Leuven, which is a large multi-disciplinary research group focusing on the interaction between the person and the environment in the development of psychopathology. She has received a European Research Council (ERC) Consolidator grant (INTERACT) and Proof of Concept grant (IMPACT). With these grants professor Germeys and her team researched a new mobile self-management therapy for patients with a psychotic disorder. The Acceptance and Commitment Therapy in Daily Life (ACT-DL) was further developed for the clinical environment. In line with that the Horizon 2020 IMMERSE project aims to thoroughly evaluate strategies, processes, and outcomes of implementing a digital mobile mental health solution.